Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G47delta trial in progressive malignant pleural mesothelioma
jRCTs033180326Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Mar 2019
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Gene Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of teserpaturev in pleural mesothelioma, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Safety - spectrum and frequency of adverse events. Started Mar 2019; status: completed.
02
Drugs
teserpaturev
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on jRCTs033180326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs033180326.